Core Insights - HCA Healthcare reported a revenue increase of 6.7% year-over-year for Q4 2025, with net income rising nearly 31% and adjusted EBITDA increasing about 11% compared to the prior year [1][5][7] Financial Performance - The company achieved its 19th consecutive quarter of volume growth, with a record of approximately 47 million patient encounters in 2025 [2][5] - Full-year 2025 results showed a consolidated adjusted EBITDA growth of 12.1% and a 90-basis-point improvement in adjusted EBITDA margin [7] - For Q4 2025, same-facility net revenue per equivalent admission increased by 2.9% year-over-year, with equivalent admissions growth of 2.4% [5][7] Capital Allocation and Investments - HCA Healthcare deployed significant capital in 2025, with capital expenditures of $4.9 billion and share repurchases totaling $10 billion [4][12] - The company announced a new $10 billion share repurchase program and increased its quarterly dividend to $0.78 per share from $0.72 [16] 2026 Outlook - For 2026, HCA Healthcare guided revenue between $76.5 billion and $80 billion, with adjusted EBITDA projected at $15.55 billion to $16.45 billion [3][9] - The guidance includes anticipated headwinds from health insurance exchange reforms and supplemental payment program changes, with an expected EBITDA impact of $600 million to $900 million [3][13] Operational Strategies - Management emphasized disciplined capital allocation and improvements in capacity management and quality outcomes as key drivers of performance [2][3] - The company is focusing on resiliency initiatives to offset expected declines in health insurance exchange volumes, with a projected 15% to 20% decline in 2026 [11][12][15] Outpatient Services - HCA Healthcare continues to invest heavily in outpatient facilities, adding approximately 100 outpatient business units in 2025 [20] - Outpatient revenue growth outpaced inpatient growth, although same-facility outpatient surgery cases saw a slight decline [19][20]